Data & AI for Health and Pharmaceuticals

Data & AI for Healthcare & Pharmaceuticals

Transforming and creating value for pharmaceuticals, hospitals, clinicals, telemedicine, biotechnologies through the power of data & AI.

Increased investments in AI are driving innovation and efficiency

Increased investments in AI are driving innovation and efficiency

The global AI in healthcare market was valued at $19.54 billion in 2023 and is projected to reach $490.96 billion by 2032, with a CAGR of 43.2% (Grand View Research) (Fortune Business Insights).

Positive impact of data & AI in multiple areas for Health

Positive impact of data & AI in multiple areas for Health

Operational Efficiency: AI improves data analysis, with machine learning helping to structure 97% of previously unused healthcare data. (Healthtech Solutions).
Medical Imaging and Diagnostics: AI tools enhance diagnostic accuracy and reduce interpretation times for medical images, aiding in early disease detection. (Healthtech Solutions) (Grand View Research).

Shorter Time to Market and improved patient experience

Shorter Time to Market and improved patient experience

Drug Discovery and Development: AI reduces drug discovery times from 5-6 years to just one year, significantly speeding up the process. (Grand View Research) (PwC).
Personalized Medicine: AI analyzes genomic and medical data to develop personalized treatment plans, improving treatment efficacy. (Fortune Business Insights) (PwC).

Client case SERVIER

AI for Health: How AI is reshaping pharmaceuticals companies.

Client Cases in Healthcare and Pharmaceuticals

SANOFI CHC Precision Marketing – Industrialising the deployment of data-driven...

PIERRE FABRE GROUP Accelerating online growth with a global e-Retail...

The Carnot CALYM Institute Fighting against lymphoma with Artificial Intelligence

SANOFI CHC Driving Digital Transformation With Precision Marketing‌‌

PIERRE FABRE COSMÉTIQUES Using Precision Marketing to change the customer...

Generative AI for Healthcare Report

Unlocking the potential of Generative AI for patients, practitioners and pharmaceutical companies.

Download the Report

November 21th, 2024
Station F, Paris

Our expert contents about Health & Pharmaceuticals Services

We are data, AI and digital experts sharing our insights and latest market updates.

Stanislas Niox-Chateau, CEO of DOCTOLIB at the Adopt AI Summit – Building the healthcare we all dream of, thanks to AI
Read more

Virgine Dominguez, Exec VP Digital, Data & Info Systems at SERVIER at the Adopt AI Summit – How AI is reshaping pharmaceutical companies
Read more

Stress in the NHS: why the UK pharmacy industry needs to embrace data
Read more

How AI is improving the patient care journey
Read more

Our Artefact Leaders in Healthcare & Pharmaceuticals

Justine NERCE

Justine NERCE

Managing Partner

Thomas FILAIRE

Thomas FILAIRE

Partner

Alexandra MANGEARD

Alexandra MANGEARD

Partner

Paul DE BALINCOURT

Paul DE BALINCOURT

Partner

Marine SORTAIS

Marine SORTAIS

Director

Kevin CHEUNG

Kevin CHEUNG

Director